◆ 会议时间：2024年10月24-26日
◆ 会议地点：日本 福冈

◆ 会议简介：

2024年第62届日本临床肿瘤学会(JSCO)年会将于2024年10月24-26日在日本福冈举行，预计有超过9000余名专业人士与会。

日本临床肿瘤学会/日本癌治疗学会(JSCO)成立于1963年，是日本领先的专业医学组织，致力于推动临床肿瘤学专业的发展，促进多学科的癌症治疗和护理方法；JSCO的使命是宣研究恶性疾病并在治疗中取得进展。JSCO现为日本最大的临床肿瘤学组织，现拥有17000余名成员，其成员来自20多个不同的专业领域，包括外科医生、肿瘤内科医生、泌尿科医生、妇科医生、放射科医师等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

第62回日本癌治療学会学術集会
The 62nd Annual Meeting of Japan Society of Clinical Oncology (JSCO2024)

会期/Date:
October 24-26, 2024

会場/Venue:
福岡コンベンションセンター / Fukuoka Convention Center, Japan

テーマ/Theme:
がんを知り、がんと向き合い、未来を生きる
Live for the future with facing cancer

摘要征文投稿：

演題募集期間: 2024 年 2月 14日（水） ～ 4月 24日（水）正午

Abstract Submission for Free papers: February 14 (Wed) - Noon, April 24 (Wed) , 2024 JST

点此提交摘要>>>Submit Abstract>>>

Greeting

I am pleased to announce that the 62nd Annual Meeting of the Japanese Society of Clinical Oncology (JSCO2024) will be held from October 24 (Thursday) to October 26 (Saturday), 2024, at the Fukuoka Convention Center. It is with great honor that we host this historical and traditional academic meeting, and we extend our sincere gratitude to President Takayuki Yoshino, former President Yuichiro Doki, and all directors, delegates, and members of the Japan Society of Clinical Oncology (JSCO).

This marks a significant milestone for Okayama University, as it will be the first time the university has taken on the responsibility of hosting the society’s meeting since Professor Kunzo Orita organized the 32nd meeting in Okayama in 1994. Our dedicated preparations aim to ensure the satisfaction of all participants, making this a memorable experience for everyone involved.

Cancer poses a diverse and formidable challenge. However, our progress in understanding its nature has been steady, thanks to the collaborative efforts of researchers, clinicians, medical staff, and various experts in the field. Various approaches such as genomic medicine, immunotherapy, robot-assisted surgery, and artificial intelligence (AI) have been employed to confront this disease. As a result, the number of treatable cancers is gradually increasing. Moreover, as we face new challenges like preventing cancer at the pre-disease stage and survive with cancer through sustainable treatments, we can engage in discussions about the future of cancer treatment. Patients now find themselves in an era where they can look forward to a positive future.

This brings us to the theme of this academic meeting: "Live for the Future with Facing Cancer". The Japanese Society of Clinical Oncology, being a multidisciplinary and cross-occupational society with over 16,000 members, aims to provide a platform where everyone involved with cancer, from specialists to patients, can deepen their understanding of cancer, confront it with diverse strategies, and discuss the bright future.

For over 30 years, I have been involved in the development of innovative medical technologies, such as gene therapy and viral therapy for cancer. Thus, in the curret meeting we will not only cover conventional topics but also focus on "Drug Discovery" and "Medical Device Development" with an eye on exit strategies. We are planning special sessions to involve bio-ventures, pharmaceutical company’s institutes, and medical device and diagnostic manufacturers who actively engage in fascinating medical seeds development. We are organizing the program to include 15 sessions ranging from basic research to advanced medical development, tailored for the themes "Understanding Cancer," "Confronting Cancer," and "Living for the Future."

Furthermore, we will inform you as soon as preparations are complete regarding our other engaging sessions, including 35 organ-specific sessions, 32 cross-disciplinary sessions, joint symposiums with the ASCO and ESMO, and other captivating sessions (such as the JSCO “Frontier” session), all which will be disseminated globally JSCO. Additionally, considering the exhibition venue is a crucial hub for information dissemination and collection, we aim to create a “Wonderland” that will evoke surprise and inspiration for all those who attend.

In conclusion, we sincerely invite you to the beautiful and culinary city of Fukuoka, where history and culture blend seamlessly. Even while in Fukuoka, we plan to provide arrangements that will allow you to fully enjoy the charm of "Sunny Okayama". We look forward to the opportunity for leading figures in cancer treatment to gather and engage in deep face-to-face interactions. I am excited about the prospect of meeting you all in Fukuoka.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。